Announcements

Job offersmore »

Tweeting Growers

Top 5 - yesterday

Top 5 - last week

Top 5 - last month

Exchange ratesmore »




CAN (QC): Planning underway for new Quebec cannabis project

MYM Nutraceuticals announces that GGS Structures and CannaCanada, subsidiary of MYM, are working together on the planning and design of the 1.5 million sq. ft. Weedon Cannabis Greenhouse Production Project.

Gerry Harrison of GGS Structures commented, "We are thrilled to be working with MYM Nutraceuticals on their project located at Weedon, Quebec. Planning is underway for the first phase of a greenhouse medical cannabis cultivation facility of approximately 100,000 sf. The completed state of the art growing facility will consist of 15 greenhouses that will total 1,500,000 sq. sf."

Weedon Health Canada commercial cannabis production license application has been submitted. MYM's consultants Factotum Consultants, who have successfully obtained Licensed Producer licenses for other clients, are managing the ACMPR application process and have submitted the Weedon application to Health Canada on June 28, 2017.

Weedon quality assurance position filled
David O'Halloran, BSc. has joined the MYM/CanaCanada team as the Quality Assurance Person for the Weedon Project. David O'Halloran brings sixteen years of Quality Assurance and Regulatory Affairs experience to the team. Having graduated from the Cork Institute of Technology in Ireland with a Bachelor of Science in Pharmaceutical Chemistry, David spent five years working in the laboratories of Novartis in the south Coast of Ireland. In 2006, he immigrated to Canada where he began working for PharmAthene Canada Inc., the Canadian division of an American biotech company contracted by the US Department of Defense to develop countermeasures for chemical and biological warfare. Following that he spent two years as Quality Assurance and Regulatory Affairs Director with Vivier Pharma.

David has since been consulting for companies to obtain their licenses from Health Canada, first under the Marihuana for Medical Purposes Regulations (MMPR), and later, the Access to Cannabis for Medical Purposes Regulations (AMPR), submitting applications on behalf of the companies, setting up quality management systems and helping in the design of production facilities to ensure optimal production efficiency and regulatory compliance.

For more information:
MYM Nutraceuticals
1-855-696-2261
info@mymarijuana.ca
www.mymarijuana.ca


GGS Structures
ggs-greenhouse.com

Publication date: 6/30/2017

 


 

Other news in this sector:

7/21/2017 Canada’s premiers discuss delaying MJ legalization
7/21/2017 Australia: The Hydroponics Company granted cannabis research licence
7/21/2017 US: Puration acquires 25-greenhouse grow operation
7/20/2017 Canadian firm invests in African MMJ cultivation
7/20/2017 CAN (BC): Nicolas Elbaze joins Sublime team
7/20/2017 US (CO): Grower optimizes cannabis operation for hot climate
7/20/2017 US (CA): Do's and don'ts of cannabis and crop protection
7/19/2017 US (WA): MCOA receives funding for 30,000 sq. ft. greenhouse
7/19/2017 Uruguay legalizes over-the-counter cannabis sales
7/18/2017 US states say 'yes' to MMJ, federal govt says 'no'
7/18/2017 US: Hawaii's MMJ industry not getting off the ground
7/17/2017 Australia: Victorian minister finds MMJ inspiration in Canada and Israel
7/14/2017 Greece legalises marijuana for medical purposes
7/14/2017 Puerto Rico enacts medicinal marijuana law
7/14/2017 US (AR): No applications yet for MMJ cultivation
7/13/2017 US (NV): Two more recreational MJ licenses for Marapharm
7/13/2017 CAN (ON): Former rose farm becomes MMJ operation
7/13/2017 CAN (ON): Police monitoring marijuana grow-op at former flowers greenhouse
7/12/2017 US (AZ): Merger creates large Arizona MMJ farm
7/11/2017 US (NV): 'State of emergency' due to marijuana shortage